Cannabidiol, also known as CBD, has risen dramatically in popularity as a treatment to reduce stress and for good reason. It is available for internal use in many forms, including CBD oil, which is oil that contains a concentration of CBD. When placed and held under the tongue, CBD oil reaches the bloodstream quickly and begins offering benefits both relatively fast, through consistent use, over time. Research is showing more and more ways CBD oil benefits the body by helping to reduce pain, resulting in a wide range of positive effects. These include the compound’s anti-inflammatory, neuroprotective, anti-epileptic, anti-anxiety and antipsychotic properties, although many users turn to the compound simply for everyday stress reduction without the mind-altering side effects of marijuana.
Sativa Investments (LON:SATI) will look for well-placed opportunities within the dynamic regulatory environment of the Medicinal Cannabis sector and the Company’s investment strategy focuses on the production, testing and compliance, research and development, including pharmacology, commercialisation and sales and marketing of Medicinal Cannabis in jurisdictions where it is regulatorily accepted. The Company has committed to an independent legal review prior to each investment to verify compliance with the prevailing regulatory environment.